Details of the Drug

General Information of Drug (ID: DMD8RLY)

Drug Name

GEN3009

Indication

Disease Entry	ICD 11	Status	REF
B-cell non-hodgkin lymphoma	2B33.5	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Antibody

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT04358458) First-in-Human (FIH) Trial of GEN3009 in Subjects With Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of AbbVie.